Plant Health Care PLC
26 September 2006
Embargoed until 7am 26 September 2006
Plant Health Care plc
('PHC' or 'the Group')
Myconate - 2006 Trial Results continue to impress around the world
Plant Health Care (AIM: PHC.L), a leading provider of natural products for
plants and soil, is pleased to report the early success of its Myconate test
programme in 2006. Building upon the impressive results from prior years, the
results of this year's trials to date further validate the effectiveness of
Myconate in increasing yields of many different crops all over the world.
PHC's novel Myconate technology helps crops to develop larger root mass by
triggering the colonisation of beneficial micro-organisms called mycorrhizal
fungi. With more mycorrhizal fungi at work, each plant can draw more nutrients
and moisture out of the soil. More nutrients make for healthier plants, and
significantly greater overall yields. The Board believes Myconate could be the
key to changing the face of farming. The safety and ease of application of
Myconate means that management practices need not be over-hauled. The procedure
is a straightforward blending process, either tank mixing the Myconate with the
fertilizer during planting, or applying the Myconate to the seed before
planting.
During 2006, Myconate tests are being performed in numerous countries in the
Americas and Europe, in different soil and climate conditions, with the tests
conducted on many different crops and using a range of application methods. The
results for four of the trials harvested so far this year are shown in the
following Table. The results from all of our corn and soybean trials will be
reported later.
CROP: LOCATION % YIELD INCREASE COMMENTS
OVER CONTROL
-----------------------------------------------------------------------------
Cotton Georgia, USA 6.9 -10.4% Lint yield,
2 rates used
Cotton Coahuila, Mexico 28.6% Lint yield
Sorghum Tamaulipas, Mexico 47.1% Grain yield
Tomatoes Provence, France 13.3% (saleable) Processing tomatoes
Our trials continue to generate interest in Myconate among its target markets
prior to commercial rollout. PHC is currently in discussions with several major
agrichemical and seed companies concerning optimal arrangements for the
commercialisation of Myconate in the principal row crops. Other strategies are
being explored for the smaller acreage crops.
John Brady, CEO of Plant Health Care, commented on the results, 'The current
trials on cotton and tomatoes have been exceptional and further tests on a
variety of different crops are underway, leading us to believe that Myconate
could be more widely accepted than previously believed.
'We are very excited about the progress being made on current round of Myconate
tests. These successes have put us ahead of where we expected to be and it bodes
very well for the future. We expect to sign the first licensing agreement with a
major agri-chemical company in 2007, one year ahead of schedule.'
-ends-
For further information please contact:
Plant Health Care plc
John Brady, CEO Tel: 001 603 525 3702
Tavistock Communications Tel: 020 7920 3150
Jeremy Carey
Christian Taylor-Wilkinson
Notes to Editors:
About Plant Health Care
Plant Health Care plc ('PHC') is a leading provider of natural products for
plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United
States, PHC currently has approximately 70 employees and has operations in the
US, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM market
of the London Stock Exchange in July 2004. Ticker symbol is PHC.
PHC's products are aimed at the landscape, agriculture and land reclamation
industries and are both environmentally beneficial and on the whole more cost
effective than synthetic chemical alternatives. Through the commercialisation of
these products, PHC is capitalising on current long-term trends toward natural
systems and biological products for plant care and soil and water management.
Web Site: www.planthealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.